Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
PCR: Page 2
Nonprofit health system adopts Immunexpress test for detecting sepsis
By
Nick Paul Taylor
FirstHealth of the Carolinas, a nonprofit health system licensed for four hospitals in North Carolina, will use Immunexpress’ SeptiCyte Rapid test to help differentiate sepsis-positive cases from patients with infection-negative systemic inflammation.
August 23, 2023
ChromaCode starts early-access launch of lung cancer variant test
By
Nick Paul Taylor
The test is designed to address diagnostic problems that prevent patients from undergoing timely cancer biomarker testing and receiving targeted therapies.
August 15, 2023
Studies show Pathnostics UTI test required fewer resources, reduced costs compared to standard testing
By
LabPulse.com staff writers
In the study, the average one-year costs related to UTIs were $501.85 lower for patients receiving treatment based on the Guidance test than for those receiving treatment based on the traditional culture test.
June 20, 2023
Roche receives WHO prequalification for HPV screening tool
By
LabPulse.com staff writers
Prequalification helps expand access to the screening tool in countries that rely on the WHO's list of prequalified suppliers in making purchasing and implementation decisions.
June 13, 2023
Eurobio Scientific obtains IVDR CE markings for PCR tests
By
LabPulse.com staff writers
The CE markings enable the firm to market three of its PCR tests as class C in vitro diagnostic medical devices for the detection of infectious diseases.
May 24, 2023
A. Menarini launches full automated MDx platform at WorldLab-EuroMedLab
By
LabPulse.com staff writers
The system, Prime MDx, is an all-in-one, sample-to-result platform designed to allows users to process a variety of sample types through real-time polymerase chain reaction (PCR), the Florence, Italy-based firm said.
May 23, 2023
BioMĂ©rieux receives FDA CLIA waiver for multiplex PCR respiratory panel
By
LabPulse.com staff writers
In about 15 minutes, the panel detects five of the most common viral causes of upper respiratory tract infections: SARS-CoV-2, influenza A, influenza B, respiratory syncytial virus (RSV), and rhinovirus.
May 11, 2023
Bio-Rad Laboratories Q1 net sales drop 3%; firm lowers full-year guidance
By
LabPulse.com staff writers
Bio-Rad shares were down on Friday, a day after the firm updated its financial outlook for full-year 2023; it anticipates non-GAAP currency-neutral revenue growth of approximately 4.5% compared to its previous estimate of 6% to 7%.
May 5, 2023
Qiagen launching syndromic molecular diagnostic system with respiratory panel in Japan
By
LabPulse.com staff writers
Qiagen said Monday that its QIAstat-Dx syndromic testing system is expected to be available soon in Japan with a SARS-CoV-2 Respiratory Panel that can detect more than 20 pathogens from a patient sample.
April 24, 2023
Curative spins off Sensible Diagnostics to commercialize point-of-care PCR platform
By
LabPulse.com staff writers
The spin-off is utilizing the experience Curative has gained with its diagnostics business during the pandemic, having run more than two million molecular point-of-care COVID-19 tests.
April 24, 2023
Seegene collaborates with Hy Laboratories, seeks similar deals to broaden syndromic testing
By
LabPulse.com staff writers
Embracing an open innovation model, the company is seeking leading companies to join a collaborative network and collectively develop hundreds, or more, of syndromic PCR assays annually to serve both local and global markets.
March 28, 2023
Long COVID less likely after Omicron than after original virus, Swiss researchers find
By
Elissa Wolfson
In a Swiss study, investigators have found that long COVID is less likely after Omicron infection than after infection by the original wild-type SARS-CoV-2 virus.
March 9, 2023
Previous Page
Page 2 of 23
Next Page
